Xeris Biopharma Holdings, Inc. [XERS] - appoints Menassie Taddese as Director
Effective November 2, 2026, Xeris Biopharma Holdings, Inc. appointed Menassie Taddese as a Class II director, increasing the Board size to nine members, with his term expiring at the 2029 annual meeting of stockholders.
Why this matters
Generating analysis…